These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
211 related articles for article (PubMed ID: 9472822)
41. Monte Carlo calculations of dose distributions around 32P and 198Au stents for intravascular brachytherapy. Reynaert N; Verhaegen F; Taeymans Y; Van Eijkeren M; Thierens H Med Phys; 1999 Aug; 26(8):1484-91. PubMed ID: 10501047 [TBL] [Abstract][Full Text] [Related]
42. [Current status of intracoronary brachytherapy]. Sabaté M Rev Esp Cardiol; 2001 Oct; 54(10):1197-209. PubMed ID: 11591301 [TBL] [Abstract][Full Text] [Related]
43. Results of intracoronary beta-brachytherapy administered by 60 mm transfer device/radiation source train: a subgroup analysis from the RENO registry. Jain D; Lorenzen HP; Hartmann F; Wegscheider K; Bonan R; Urban P; Schunkert H; J Invasive Cardiol; 2004 Jul; 16(7):363-7. PubMed ID: 15282429 [TBL] [Abstract][Full Text] [Related]
44. Effective and efficient strategies for coronary revascularization in the drug-eluting stent era. Lepor NE; Madyoon H; Kereiakes D Rev Cardiovasc Med; 2002; 3 Suppl 5():S38-50. PubMed ID: 12478234 [TBL] [Abstract][Full Text] [Related]
45. Intracoronary brachytherapy. Treatment of in-stent restenosis with the Beta-Cath system. Initial experience in Latin America. Muñoz JS; Feres F; Abizaid AC; Mattos LA; Staico R; Centemero M; Tanajura LF; Pinto I; Sousa AG; Sousa JE Arq Bras Cardiol; 2004 Jul; 83(1):63-8; 57-62. PubMed ID: 15322668 [TBL] [Abstract][Full Text] [Related]
46. Comparison of a centered 32P source wire system with a noncentered 90Sr/Y brachytherapy system for intracoronary beta-radiation following PCI of diffuse in-stent restenosis. Haase J; von Neumann-Cosel P; Damm M; Hofmann M; Störger H; Isner D; Bergmann M; Piancatelli C; Schächinger V; Schwarz F Cardiovasc Revasc Med; 2005; 6(4):140-6. PubMed ID: 16326374 [TBL] [Abstract][Full Text] [Related]
47. Intracoronary beta-radiation for the treatment of patients at very high risk for recurrence of in-stent restenosis: a single center experience. Parenti DZ; Marsico F; Tosi G; Catalano G; Maiello L; Milone F; Carcagnì A; Pron PG; Orecchia R; Presbitero P Ital Heart J; 2003 Mar; 4(3):199-204. PubMed ID: 12784747 [TBL] [Abstract][Full Text] [Related]
48. The radioisotope stent for the prevention of restenosis. Fischell TA; Hehrlein C Herz; 1998 Sep; 23(6):373-9. PubMed ID: 9816524 [TBL] [Abstract][Full Text] [Related]
49. [Standards in interventional therapy of coronary artery disease]. Rutsch W; Gliech V; Dübel HP; Borges A; Theres H; Laule M; Baumann G Herz; 2002 Sep; 27(6):481-501. PubMed ID: 12378393 [TBL] [Abstract][Full Text] [Related]
50. Vascular brachytherapy: applications in the era of drug-eluting stents. Waksman R Rev Cardiovasc Med; 2002; 3 Suppl 5():S23-30. PubMed ID: 12478232 [TBL] [Abstract][Full Text] [Related]
51. Monte Carlo dose calculations of beta-emitting sources for intravascular brachytherapy: a comparison between EGS4, EGSnrc, and MCNP. Wang R; Li XA Med Phys; 2001 Feb; 28(2):134-41. PubMed ID: 11243335 [TBL] [Abstract][Full Text] [Related]
53. Clinical outcome of patients undergoing low aggressive angioplasty combined with brachytherapy and short-term dual antiplatelet therapy for in-stent restenosis. Di Pede F; Buja P; Millosevich P; Grassi G; Celestre M; Zuin G; Marchetti C; Pizzi G; Antonello M; Bindoni L; Raviele A J Cardiovasc Med (Hagerstown); 2006 Oct; 7(10):731-6. PubMed ID: 17001233 [TBL] [Abstract][Full Text] [Related]
54. [Can radiotherapy reduce the frequency of restenosis after coronary angioplasty?]. Langberg CW; Solheim S; Hagen S Tidsskr Nor Laegeforen; 2000 Feb; 120(6):707-10. PubMed ID: 10806885 [TBL] [Abstract][Full Text] [Related]
55. Feasibility and safety of beta irradiation in human coronary arteries. Urban P; Verin V; Popowski Y; Rutishauser W Semin Interv Cardiol; 1997 Jun; 2(2):125-31. PubMed ID: 9546993 [TBL] [Abstract][Full Text] [Related]
56. Progress in clinical trials for coronary arterial restenosis using beta radiation sources. Waksman R Cardiovasc Radiat Med; 1999; 1(3):220-6. PubMed ID: 11272365 [TBL] [Abstract][Full Text] [Related]
57. Feasibility and safety of intra-coronary Beta irradiation with 144Ce/Pr for prevention of restenosis after percutaneous transluminal coronary angioplasty of in-stent restenotic lesions. Bonvini RF; Hendiri T; Leo G; Aeby N; Noble J; Sigwart U; Verin V Acute Card Care; 2006; 8(4):217-23. PubMed ID: 17162548 [TBL] [Abstract][Full Text] [Related]
58. Randomized blinded clinical trial of intracoronary brachytherapy with 90Sr/Y beta-radiation for the prevention of restenosis after stent implantation in native coronary arteries in diabetic patients. Syeda B; Schukro C; Kirisits C; Lang I; Siostrzonek P; Gottsauner-Wolf M; Pokrajac B; Schmid R; Yahya N; Pötter R; Glogar D Radiother Oncol; 2006 Jan; 78(1):60-6. PubMed ID: 16309769 [TBL] [Abstract][Full Text] [Related]
59. Intracoronary radiation for prevention of restenosis: dose perturbations caused by stents. Amols HI; Trichter F; Weinberger J Circulation; 1998 Nov; 98(19):2024-9. PubMed ID: 9808600 [TBL] [Abstract][Full Text] [Related]
60. Dose distribution for a 32P-impregnated coronary stent: comparison of theoretical calculations and measurements with radiochromic film. Duggan DM; Coffey CW; Levit S Int J Radiat Oncol Biol Phys; 1998 Feb; 40(3):713-20. PubMed ID: 9486624 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]